APP and amyloidosis: In transgenic mice with overexpressing β-amyloid precursor protein (APP) and presenilin1 (PS1) (models of Alzheimer’s disease), an increase in astroglial connexin immunoreactivity specifically around the β-amyloid plaques was documented.